- Filter by
- Categories
- Tags
- Show all
- Article
- Confusion
- Contract
- Copyright
- Corporate
- Domain Names
- Employment
- Expungement
- Expungement
- Grey Marketing
- Industrial Designs
- Licensing
- Obviousness
- Opposition
- Passing Off
- Patent
- Patent Infringement
- Patent Strategy
- PM(NOC)
- Procedure
- Prosecution
- recognition
- Services
- Summary
- Trade Secrets
- Trade-mark
- Use
- Validity
- 2019
- 35 US Code §101
- 3D printing
- 6.08
- Abandonment
- abstract
- abstract theorems
- accounting of profits
- acquired distinctiveness
- actions
- actual notice
- agreement
- agreements
- airport security
- Alice/Mayo Test
- Ambiguity
- Amending
- amendment
- Amendments
- annual maintenance fee
- Anticipation
- Appeal
- application
- application chain
- application fee
- arbitrary
- arbitration
- Assignment
- Australia
- Bad Faith
- bill
- Bill C-31
- Bill C-43
- Bill C-8
- Bill C-86
- biologics
- biosimilar
- Biotech Patents
- Blockchain
- border measures
- Brand
- branding
- broadcasting
- budget
- burden of proof
- business
- CAFC
- call processing
- Canada
- Canada Gazette
- Cannabis Law
- causal link
- cdrp
- CEEO
- Certificate of Supplementary Protection
- champerty
- Chemical Patent
- chemistry
- ciba
- CIPO
- CIPO errors
- CIRA
- Claim Construction
- Class Actions
- clerical error
- college of agents
- combination
- combination drugs
- commissioner
- Common General Knowledge
- Complete Code
- confidential
- Confidential Information
- confidentiality
- confidentiality order
- Conflict of Interest
- confusing
- confusingly similar
- confusion
- constitution
- constitutional
- constitutionality
- consumer goods
- contract
- contributory infringement
- Copyright
- Copyright Infringement
- copyright test
- corrections
- Costs
- counterfeit
- COVID-19
- CSP
- cybersecurity
- Damages
- Data
- Data Protection
- deadline
- deadlines
- defamation
- defences
- delay to market entry
- delayed market entry
- descriptive
- Design Patents
- deviation
- digital infringement
- disclosure
- distinctive
- distinctive feature
- distinctiveness
- Diversity
- division of powers
- divisionals
- DNA Patents
- domain
- domain names
- dominant feature
- dosage range
- Double Patenting
- doubtful cases
- due care
- E-Commerce
- Early dismissal
- economics
- errors
- essentiality of elements
- Ethics
- Europe
- Events
- Evidence
- examination quality
- examination statistics
- Examiner
- expert
- expert blinding
- expert evidence
- Experts
- expiry
- Expungement
- extraterritoriality
- federal circuit
- Federal Court
- Federal Court of Appeal
- fee
- fees
- file wrapper
- Filing
- filing date
- filing fee
- financial services
- foreign issue estoppel
- forum selection
- fraud
- Free World Trust
- frivolous
- funding
- future infringement
- generics
- geographical indications
- global
- Good Faith
- goods
- Government
- grace period
- grey marketing
- Hague
- hearsay
- hearsay evidence
- Honest Contractual Performance
- ICSID
- Illegality
- Improver
- imunity
- Indefiniteness
- Inducement
- Industrial Designs
- inherent distinctiveness
- injunction
- Injunctions
- Innovation
- insufficiency
- insufficient disclosure
- Intellectual Property
- intent
- Inter Partes Review
- interlocutory injunction
- Internet
- intra vires
- invalidated
- invalidation
- inventor removal
- inventorship
- IP Lawyer
- IP management
- ip regime
- IP Strategy
- IPIC
- IPO
- ISP
- IT patent
- ITC
- Jurisdiction
- Late fee
- Legal Retainer
- legal test
- legislative reform
- legitimate interest
- Licensing
- life science
- limitation periods
- Litigation
- litigation evidence
- litigation funding agreement
- madrid
- maintenance
- material facts
- materiality
- method
- Methods of Medical Treatment
- minister of health
- misleading
- monopoly
- motion
- Motion to dismiss
- Motion to strike
- NAFTA
- national phase entry
- new act
- new evidence
- no chance of success
- Non-Infringing Alternative
- notice of allegation
- notice to rectify
- novelty
- obivous error
- Obviousness
- Office
- official mark
- official marks
- on-sale
- on-sale bar
- Online
- ontario
- opposition
- outsourcing
- Overbreadth
- overlapping
- ownership
- Ownership & Inventorship
- PAB
- Passing Off
- patent abandonment
- Patent Act
- patent agent
- Patent Agents
- Patent and Trademark Appeal Board
- patent appeal board
- Patent Application
- Patent Drafting
- Patent Infringement
- Patent Litigation
- Patent Office
- patent office errors
- patent owner
- patent ownership
- patent practicioner
- patent prosecution
- patent protection
- patent requirement
- Patent Rules
- Patent Strategy
- patent term adjustment
- Patent Textbook
- Patent Trolls
- patentability
- Patentable Subject Matter
- Patents
- PCT
- Pharmaceutical Patent
- Pharmaceutical Pricing
- PLT
- PM(NOC)
- PM(NOC) Damages
- PMPRB
- POSITA
- price regulation
- pride
- prior art
- prior disclosure
- prior disclosure defence
- prior use
- priority
- priority claim
- priority claims
- priority date
- Privilege
- procedure
- Product Specificity
- profit
- prohibited marks
- Promise Doctrine
- proprietor
- Prosecution
- Prosecution History
- protective order
- prothonotaries
- Provisional Patent
- public sale
- Public Servant
- Punitive Damages
- Recognition
- Records
- registration
- reinstatement
- relevant date for construction
- Remedies
- representation
- request for correction
- requisition
- responding
- review
- risk
- Royalties
- s. 27
- s. 45
- s. 53
- sale
- Scheduling
- SCOTUS
- second person
- Secondary Infringement
- secondary meaning
- secret sale
- section 28
- Section 45
- section 50
- Section 52
- section 56
- section 7
- security
- selection patents
- Services
- settlement
- skilled person
- software
- Software Copyright
- Software Patent
- software patents
- Sound Prediction
- specification
- sponsorship
- SRED
- Standard of Review
- Standard-Essential Patents
- standing
- standing to appeal
- Start-up
- Startups
- statute of monopolies
- stay
- Strategy
- Sufficiency
- Summary Judgment
- summary trial
- superior court
- Supreme Court of Canada
- surname
- Technology
- Telecommunications
- test
- third party
- time frame
- top patent agent
- TPP
- Trade Secrets
- Trade-Mark
- trade-marks act
- Trademark
- Trademark Act
- trademark agent
- Trademark Infringement
- trademark opposition
- Trademarks use
- treaty
- UK
- united kingdom
- United States
- unpatentable
- untrue material allegation
- Use
- useful article
- USMCA
- USPTO
- Utility
- Validity
- variant
- Varying records
- Velocity
- vexatious
- who's who legal
April 16, 2019
April 16, 2019
2019 FCA 29 - Canada's FCA refuses to intervene in trial judge's decision with respect to punitive damages.
May 2, 2017
May 2, 2017
2017 FCA 9 - The FCA affirmed the FC decision that AstraZeneca’s patent was valid and infringed, accepted Apotex’s appeal with respects to limitation periods, and rejected AstraZeneca’s cross-appeal regarding punitive damages.
July 25, 2014
July 25, 2014
Bauer Hockey Corp v Sport Maska Inc - 2014 FCA 158 - The Court confirmed that punitive damages are available in trade-mark infringement cases, but “[a]llegations of willful and knowing infringement are alone insufficient to support a claim to punitive damages."
July 3, 2014
July 3, 2014
Teva Canada Limited v Pfizer Canada Inc, 2014 FCA 138 - The Court held that punitive and exemplary damages cannot be available where the statutory regime underlying the claim explicitly or implicitly precludes them. This is the case under the PM(NOC) Regulations.